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Peptide orientation and dynamicsBP100 is amultifunctionalmembrane-active peptide of only 11 amino acids,with a high antimicrobial activity, an
efﬁcient cell-penetrating ability, and low hemolytic side-effects. It forms an amphiphilicα-helix, similar to other
antimicrobial peptides like magainin. However, BP100 is very short and thus unlikely to form membrane-
spanning pores as proposed for longer peptides as a mechanism of action. We thus studied the conformation,
membrane alignment and dynamical behavior of BP100 in lipid bilayers (DMPC/DMPG), using oriented circular
dichroism (OCD) and solid-state 19F and 15N NMR. According to OCD and 15N NMR, the BP100 helix is oriented
roughly parallel to the membrane surface, but these methods yield no information on the azimuthal alignment
angle or the dynamics of themolecule. To address these questions, a systematic 19F NMR analysiswas performed,
which was not straightforward for this short peptide. Only a limited number of positions could be 19F-labeled, all
of which are located on one face of the helix, which was found to lead to artifacts in the data analysis. It was nev-
ertheless possible to reconcile the 19F NMRdatawith theOCD and 15NNMRdata by using an advanced dynamical
model, in which peptide mobility is described by ﬂuctuating tilt and azimuthal angles with Gaussian distribu-
tions. 19F NMR thus conﬁrmed the regularα-helical conformation of BP100, revealed its azimuthal angle, and de-
scribed its highmobility in themembrane. Furthermore, the very sensitive 19F NMR experiments showed that the
alignment of BP100 does not vary with peptide concentration over a peptide-to-lipid molar ratio from 1:10 to
1:3000.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs), also known as host defense pep-
tides, are part of the innate immune system of most organisms [1–3].
They often form cationic amphiphilic structures that can kill bacteria
by permeabilizing their membranes [4–6]. Much research has focused
on the possibilities of developing new types of antibiotics from such
peptides, as they tend to bear less risk of inducing bacterial resistance
than conventional antibiotics [3,7]. Of special interest for pharmaceuti-
cal applications are short sequences that are easy and cost-efﬁcient to
synthesize. Many groups have systematically optimized naturally oc-
curring AMPs, yielding amongst others the 11 amino acid peptide
BP100 (KKLFKKILKYL-NH2) [8]. Starting with hybrids of cecropin and
melittin [9], the promising 11-mer Pep3 was developed [10]. Amongst
22 analogs of Pep3, the one with the highest antimicrobial activity
was called BP76 [11]. In a further study, a library of 100 analogs of
BP76 was produced and evaluated, amongst which BP100 was found
to exhibit the best combination of high antimicrobial activity and lowemistry and CFN, Fritz-Haber-
222; fax: +49 721 608 44823.
ights reserved.cytotoxicity and hemolysis [8]. Atomic force microscopy revealed that
it destroys the cell envelope of Escherichia coli bacteria at aminimum in-
hibitory concentration of 3 μM [12]. This indicates that the cell mem-
brane is the target of the peptide, and that membrane damage is the
primary cause of the antibacterial effect. BP100 is a genuinely multi-
functional peptide, because it is taken up, for example, into tobacco
cells without causing leakage or being toxic [13], hence it is very useful
also as a cell-penetrating peptide (CPP).
BP100 is predicted to form an amphiphilic helical structure in the
presence of membranes, as conﬁrmed here using circular dichroism;
the helical wheel projection is shown in Fig. 1. It can be seen that one
face of the helix consists of charged Lys residues, while all hydrophobic
residues are on the opposite side. BP100 is only half as long as the well-
known α-helical AMPs of the magainin family (magainin 2 with 23
amino acids [14]; PGLa [15], MSI-103 [16] and MSI-78 [17] with 21 res-
idues each) ormaculatin 1.1with 21 residues [18]. Themode of action of
these longer peptides is attributed to the formation of pores, inwhich the
peptides assume a – possibly transient –membrane-spanning orienta-
tion to form an aqueous pore. The helix of BP100, however, is too short
to span a typical biological membrane, as it has a length of 16.5 Å
(1.5 Å per residue for an ideal α-helix) assuming that the peptide is
completely helical. Therefore, it is unlikely to form transmembrane
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Peptide name Sequence
BP100-WT KKLFKKILKYL-NH2
BP100-3L-Bpg KK-CF3-Bpg-FKKILKYL-NH2
BP100-4F-Bpg KKL-CF3-Bpg-KKILKYL-NH2
BP100-7I-Bpg KKLFKK-CF3-Bpg-LKYL-NH2
BP100-8L-Bpg KKLFKKI-CF3-Bpg-KYL-NH2
BP100-10Y-Bpg KKLFKKILK-CF3-Bpg-L-NH2
BP100-11L-Bpg KKLFKKILKY-CF3-Bpg-NH2
BP100-8L-15N KKLFKKI-15N-Leu-KYL-NH2
BP100-4F-Bpg-8L-15N KKL-CF3-Bpg-KKI-15N-Leu-KYL-NH2
BP100-7I-Bpg-8L-15N KKLFKK-CF3-Bpg-15N-Leu-KYL-NH2
Fig. 1.Helical wheel projection of BP100. The hydrophobic sector is shown in gray and the
polar sector inwhite. Charged lysine residues and the N-terminus aremarkedwith+, res-
idues labeled with CF3-Bpg are labeledwith * and Leu8which was also labeledwith 15N is
labeled with #. The sequences of all synthesized peptides are also given.
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tion of BP100 is responsible for its mechanism of action.
A well-established method of investigating helical peptides in
membranes is to determine the orientation of the helix in oriented
lipid bilayers using solid-state NMR structure analysis [19–38]. The
helix alignment is described by two angles: the tilt angle τ, deﬁned as
the angle between the long axis of the peptide and the membrane nor-
mal, and the azimuthal rotation angle ρ, which deﬁnes a rotation of the
helix around its long axis. 15N-labeling in the peptide backbone is rou-
tinely used to determine τ in straightforward 1-dimensional NMR ex-
periments [27,30,39,40]. We have thus placed a 15N-label into the
backbone amide of a single residue of BP100 (Leu8), in order to estimate
the tilt angle of this short helical peptide in membranes. 13C NMR pro-
vides another, more sensitive approach to determine the orientation
of peptides in membranes [32,35]. An even more sensitive method,
based on the use of selective CF3-labels, has been established by our
group to obtain both τ and ρ with simple one-pulse 19F NMR experi-
ments [22–26,36,40–70]. In the present study, we have thus labeled
BP100 with CF3-L-Bpg [3-(triﬂuoromethyl)-L-bicyclopent-[1.1.1]-1-
ylglycine] [68], replacing all hydrophobic residues, one at a time. This
strategy has been successfully employed to characterize several longer
AMPs, but has not been used on any short peptides such as BP100 or
temporins. The selective substitution of each hydrophobic residue in
BP100 by CF3-L-Bpg is routinely feasible, but one should bear in mind
that the 19F NMR data analysis will only yield meaningful results if a
high degree of secondary structure can be evidenced by CD, as demon-
strated below. Membrane-bound BP100 indeed shows an unusually
high helicity for an 11-mer peptide, which makes it a perfect candidate
to examine the advantages and limitations of solid-state 19F NMR struc-
ture analysis for shorter peptides. Given the short length of BP100 and
the presence of 5 charged Lys residues forming a large polar sector
(see Fig. 1), we note that all remaining hydrophobic residues that are
available for replacement with CF3-L-Bpg lie on one face of the helix.
This arrangement can be expected to make the NMR data analysis un-
certain, as will be demonstrated below. To overcome this potential am-
biguity and to additionally test the inﬂuence of CF3-L-Bpg labeling on
this short peptide, non-perturbing 15N-labels were introduced notonly in the wild type BP100 (free of CF3-L-Bpg), but also in some19F-
labeled analogs (see Fig. 1).
Traditionally, membrane-bound peptides have been described only
in terms of τ and ρ, but recently whole-body motions have been intro-
duced as additional parameters in the NMR data analysis [71–73]. For
several longAMPs it has been shown that theirmotions do not inﬂuence
the NMR analysis much [72,74], whereas for some transmembrane he-
lices of similar length it was crucial to take dynamics into account
[72,75,76]. Here, we analyze the importance of dynamics for BP100,
given that this very short peptide is likely to undergo more extensive
ﬂuctuations in liquid-crystalline membranes than the longer AMPs
studied before. We furthermore combine 19F and 15N NMRwith orient-
ed circular dichroism (OCD) [77], an independent qualitativemethod to
obtain orientational information on membrane-embedded α-helical
peptides [47,78–86]. By using all these techniques tomeasure the orien-
tation of BP100 in the same kind of oriented DMPC/DMPG samples,
which are supposed to mimic microbial membranes, we show that the
use of several complementary methods is advisable to get reliable re-
sults. Especially for very short peptides like BP100, dynamical effects
are found to be much more important than for longer ones such as
PGLa or magainin 2, and special care must be taken to include this mo-
bility in an appropriate way in the ﬁnal description of the system.
2. Materials and methods
2.1. Materials
Fmoc-protected amino acids and coupling reagents used for peptide
synthesis were purchased from Iris Biotech GmbH (Marktredwitz,
Germany) or Novabiochem (Merck Chemicals Ltd., Nottingham, UK).
The 19F-labeled amino acid 3-(triﬂuoromethyl)-L-bicyclopent-[1.1.1]-
1-ylglycine (CF3-Bpg) was purchased from Enamine (Kiev, Ukraine).
Solvents for synthesis and puriﬁcation were purchased from Biosolve
(Valkenswaard, The Netherlands) or Acros Organics (Geel, Belgium).
UV-grade chloroform and methanol used for sample preparation
were obtained from VWR International (Bruchsal, Germany). The lipids
1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine (DMPC) and 1,2-
dimyristoyl-sn-glycero-3-phosphatidylglycerol (DMPG) were pur-
chased from Avanti Polar Lipids (Alabaster, AL) and used without fur-
ther puriﬁcation.
2.2. Peptide synthesis
BP100, with the sequence KKLFKKILKYL-NH2, was synthesized with
a single CF3-L-Bpg at six different positions (Leu3, Phe4, Ile7, Leu8,
Tyr10, or Leu11); with 15N-labeled leucine (15N-Leu) at position Leu8;
or with both 15N at Leu8 and CF3-L-Bpg at either Phe4 or Ile7. The
synthesized peptides are listed in Fig. 1 with sequences and the abbrevi-
ations used in this article. Standard Fmoc-solid phase synthesis protocols
were used [87] on an automated Liberty 1microwave peptide synthesiz-
er (CEM, Kamp-Lintfort, Germany), or on an automated Syro II peptide
synthesizer (MultiSynTech, Witten, Germany). Peptides were puriﬁed
using C18 reverse phaseHPLC columnswithwater/acetonitrile gradients
each containing 5 mM HCl as ion pairing agent. The identity of the pep-
tides was conﬁrmed by an LC–MS system equipped with an 1100 Series
LC-system from Agilent (Santa Clara, USA) coupled to an ESI micro-TOF
mass spectrometer from Bruker Daltonics (Bremen, Germany).
2.3. Circular dichroism (CD) spectropolarimetry
The lipid powders (DMPC, DMPG) were dissolved in chloroform/
methanol 50/50 (v/v) to obtain 14 mM stock solutions. Aliquots of the
stock solutions were mixed in a glass vial and thoroughly vortexed to
obtain the DMPC/DMPG 3:1 mixture (molar ratio). Subsequently, the
organic solvents were removed under a gentle stream of nitrogen,
followed by overnight vacuum. The lipid ﬁlm that had formed at the
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er (PB, pH 7.0) and homogenized by 10 freeze–thaw cycles followed by
vigorously vortexing for 1 min after each cycle. Afterward, small
unilamellar vesicles (SUVs) were formed by sonication of the MLVs for
4 min in a strong ultrasonic bath (UTR 200, Hielscher, Germany). The
sonication procedure was repeated 3 times, after cooling the water of
the ultrasonic bath down to room temperature with ice, to avoid
overheating of the samples.
To prepare the ﬁnal CD samples, an aliquot of the respective 350 μM
peptide stock solution in water was added to either pure 10 mM PB or
to a 50/50 (v/v) mixture of TFE (2,2,2-triﬂuoroethanol) and 10 mM PB
or to the DMPC/DMPG (3:1) liposome dispersion in 10 mM PB. The
ﬁnal peptide concentration was in the range 40–150 μM for the
10 mM PB solutions, 20–75 μM for the TFE/10 mM PB mixtures and in
the liposome samples it was adjusted to ~20 μM, which resulted in a
peptide-to-lipidmolar ratio (P/L) of 1:100, given the lipid concentration
of 2 mM.
CD spectra of these samples were recorded on a J-815 spectropolar-
imeter (JASCO, Groß-Umstadt, Germany). Measurements were per-
formed in quartz glass cells (Suprasil, Hellma, Müllheim, Germany) of
1 mm path length between 260 and 185 nm at 0.1 nm intervals. Spec-
tra were recorded at 20 °C for the pure PB buffer and PB/TFE mixtures,
and at 30 °C for the vesicle suspensions (i.e. above the phase transition
temperature of the lipids), using a water-thermostated rectangular cell
holder. Three repeat scans at a scan-rate of 10 nm min−1, 8 s response
time and 1 nm bandwidth were averaged for each sample and for the
baseline of the corresponding peptide-free sample. After subtracting
the baseline spectra from the sample spectra, CD data were processed
with the adaptive smoothingmethod, which is part of the Jasco Spectra
Analysis software. Finally, the spectral datawere converted tomean res-
idue ellipticities by measuring the concentration of each peptide stock
solution based on the 280 nm UV absorbance of the Tyr residue
contained in the sequence [88]. The absorption spectrum in the range
of the Tyr aromatic bandswas recorded from 340 to 240 nm in a quartz
glass half-micro-cuvette with 1 cm optical path length (Hellma,
Müllheim), using 10 mMphosphate buffer as a blank. The peptide con-
centrationwas calculated from the baseline-corrected absorbance using
amolar extinction coefﬁcient of 1490 l mol−1 cm−1 for the Tyr absorp-
tion at 280 nm [88]. The concentration of the ﬁnal CD samples was cal-
culated from the respective dilution factors.
Secondary structure estimation from CD spectra was performed
using the CDSSTR program with the implemented singular value de-
composition (SVD) algorithm [89,90], by the CONTIN-LL program,
which is based on the ridge regression algorithm [91,92], and by the
SELCON-3 program, which incorporates the self-consistent method to-
gether with the SVD algorithm to assign protein secondary struc-
ture [93,94]. The three algorithms are provided by the DICHROWEB
on-line server [95,96]. The quality of the ﬁt between experimental and
back-calculated spectrum corresponding to the estimated secondary
structure fractions was assessed from the normalized root mean square
deviation (NRMSD), with a value b0.1 (for CONTIN-LL and CDSSTR) and
b0.25 (for SELOCN-3) considered as a good ﬁt [95]. Finally, the second-
ary structure element fractions of each sample were calculated as the
mean value of the individual data obtained with the three algorithms.
2.4. Oriented circular dichroism spectroscopy (OCD)
OCD experiments on macroscopically oriented samples were per-
formed with a designated OCD-cell built in-house, which is computer
controlled and can be integrated in our J-810 spectropolarimeter as an
accessory [79]. Oriented samples of BP100-wt in DMPC/DMPG (3:1) bi-
layerswith P/L ratios of 1:100, 1:25, and 1:12.5were prepared from cor-
responding BP100-wt vesicle suspensions (for preparations of vesicles
see section on CD above). For this, a 50- to 100-μl aliquot of the sample
containing a maximum of 0.2 mg lipid was deposited on a quartz glass
plate with a 20-mm diameter. The water of the vesicle suspensionwas allowed to evaporate in a gentle stream of air until the sample ap-
peared dry (resulting in a circular spot of ~12-mm diameter). Samples
were subsequently hydrated for 15 h at 30 °C in the OCD sample cell.
A small volume of saturated K2SO4 salt solution (300–500 ml) was
placed in the bottom of the cell to maintain 97% humidity. To minimize
spectral artifacts (e.g. linear dichroism contributions) OCD spectra were
recorded at 30 °C every 45° of rotation of the cell at eight different rota-
tion angles [79], and referenced by subtracting the background signal
that was recorded with a sample containing the same amount of lipids
without peptides using the same data acquisition parameters as in the
normal CD measurements.
2.5. NMR sample preparation
Oriented NMR samples were prepared by co-dissolving the lipid and
peptide in suitable organic solvents, spreading the mixture on glass
plates, removal of the organic solvent, and subsequent hydration.
Details have been published elsewhere [50,58]. Usually 0.3 mg of
19F-labeled peptide or 0.5 mg of 15N-labeled peptidewas used, and ap-
propriate amounts of lipids to get the desired P/L ratio. For the 1:3000
sample 0.023 mg peptide was used.
2.6. Solid state NMR
31P NMR measurements to check the sample quality and degree of
lipid orientation were performed at 202.5 MHz on an Avance III Bruker
NMR spectrometer (Bruker Biospin, Karlsruhe, Germany) with a wide
bore 500 MHz magnet, using a Hahn echo sequence [97] with a 90°
pulse of 5 μs and a 30 μs echo time, with 1H SPINAL64 decoupling [98]
during acquisition. Typically 256 scans were accumulated. The acquisi-
tion time was 10 ms and the recycle time 1 s.
19FNMRwasperformed using a home-built probehead at a frequen-
cy of 470.6 MHz using an anti-ringing sequence [99] with a 90° pulse of
3.25 μs, a sweep width of 500 kHz, 4096 data points, and proton
decoupling using TPPM [100]. Depending on the amount of peptide, be-
tween 10,000 and 240,000 scans were acquired. The 19F chemical shift
was referenced using the ﬂuorine signal of a 100 mM solution of NaF,
of which the chemical shift was set to−119.5 ppm.
1H–15N cross polarization experiments using a CP-MOIST pulse se-
quence [101] were performed at 60.8 MHz on an Avance Bruker NMR
spectrometer (Bruker Biospin, Karlsruhe, Germany) with a wide bore
600 MHz magnet. The spectra were acquired using a home-built
double-tuned probe with a low-E ﬂat-coil resonator (3 mm × 9 mm
cross section), employing a 1H and 15N radiofrequency ﬁeld strength
of 65 kHz during the cross polarization, and 36 kHz 1H SPINAL16
decoupling during acquisition. A mixing time of 250 μs was found to
be optimal, and up to 14,000 scans were accumulated. The acquisition
time was 10 ms and the recycle time was 5 s. The 15N chemical shift
was referenced using the signal of a dry powder of ammonium sulfate,
of which the chemical shift was set to 26.8 ppm. All NMR experiments
were performed at 35 °C, unless otherwise stated. The temperature of
the sample inside the NMR probewas calibrated using amethanol sam-
ple [102].
2.7. NMR data analysis
The orientation of a helical peptide in the membrane is deﬁned by
two angles, the tilt angle τ, deﬁned as the angle between the long axis
of the helix and the membrane normal, and the azimuthal rotation
angle ρ, which deﬁnes the rotation of the peptide around its long axis.
For calculating the peptide orientation and dynamics, the structure of
BP100 is assumed to be an ideal α-helix, based on a poly-alanine
model generated with SYBYL (Tripos, St. Louis, USA) [23]. Using 19F
NMR data from all six labeled positions, the helix orientation is calculat-
ed from RMSD ﬁts and quadrupolar wave plots, as described in detail
previously [40]. Previously, we have deﬁned the ρ angle starting from
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residue 1 (This leads to a shift of ρ angles with -20°, i.e., a ρ angle here
found to be 159° would with the previous deﬁnition be 179°.). Peptide
dynamics were accounted for by using two different models, which
have been explained in detail elsewhere [72]. Brieﬂy, in the “implicit”
dynamical model, the local and global mobility of the peptide helix is
described by an order parameter Smol. This term reduces all 19F–19F di-
polar coupling by a factor between 0 and 1, where 0 means complete
isotropic averaging and 1 corresponds to an immobile situationwithout
any dynamics, except possible diffusional translation and rotation
around the bilayer normal, which do not inﬂuence the splittings for
peptides in membranes oriented with the bilayer normal parallel to
the magnetic ﬁeld. In the “explicit” model, dynamics is described as
Gaussian distribution of τ and ρ angles, with widths στ and σρ, respec-
tively. Larger widths correspond to a more dynamic situation, in
which the angles undergo ﬂuctuations with larger amplitudes. It is as-
sumed that the whole-body helix ﬂuctuations are fast on the NMR
time scale, so that the measured splittings represent time-averages
over these distributions [72].Fig. 2. CD spectra of BP100 and 19F-labeled analogs in (A) 10 mM PB, and (B) in the
presence of DMPC/DMPG (3:1) vesicles, P/L 1:100, 10 mM PB.
Table 1
Secondary structure fractions of BP100-wt peptide and CF3-Bpg-labeled analogs in DMPC/
DMPG (3:1) vesicles, evaluated from the CD spectra using three different algorithms.
Sample Fraction of secondary structure elementa
α-Helix β-Sheet Turn Unordered Total
BP100-wt 0.61 0.04 0.13 0.22 1.00
BP100-3L-Bpg 0.77 0.02 0.08 0.13 1.00
BP100-4F-Bpg 0.77 0.03 0.06 0.15 1.01
BP100-7I-Bpg 0.71 0.04 0.09 0.16 1.00
BP100-8L-Bpg 0.74 0.02 0.08 0.16 1.00
BP100-10Y-Bpg 0.74 0.04 0.09 0.14 1.01
BP100-11L-Bpg 0.87 0.01 0.04 0.07 0.99
a Data represent mean values of the results obtained with three different secondary
structure estimation algorithms. Individual results of the different analyses were not con-
sidered when the sum of all structural element fractions was b0.98 or N1.02, or when the
NRMSD (normalized root mean square deviation) between the experimental and back-
calculated CD spectrum was above the threshold value (0.1 for CONTIN-LL and CDSSTR,
and 0.25 for SELCON-3).3. Results
Several BP100 analogs were synthesized, either with a 15N label at
the backbone amide of Leu8, or with a single CF3-Bpg side chain as a
conservative replacement of Leu3, Phe4, Ile7, Leu8, Tyr10, or Leu11 as
shown in Fig. 1. The 15N-labels do not affect the chemical properties of
the molecule, but 19F-labeling might inﬂuence the biological function
and/or structure of the peptide. We therefore tested the antimicrobial
activity against various Gram-positive and Gram-negative strains, and
found no signiﬁcant difference between wild type BP100 and the six
19F-labeled analogs (Table A1 in SupportingMaterial).We also recorded
circular dichroism spectra to determine the conformation of these pep-
tides in 10 mM PB, in TFE/10 mM PB solution, and in the presence of
DMPC/DMPG (3:1) vesicles at a P/L ratio of 1:100. In phosphate buffer,
BP100-wt and all 19F-labeled analogs are unstructured, as seen from
the random coil spectral with a typical minimum around 198 nm and
mostly negative ellipticities over the full spectral range from 185 to
260 nm, as seen in Fig. 2A. All of the peptides fold as α-helices in
the presence of negatively charged DMPC/DMPG (3:1) vesicles, as
seen from the spectral line shapes in Fig. 2B with a positive maximum
around 192 nm and two negative bands at 208 nm and 223 nm. In
50% TFE (v/v), the peptides are also α-helical (see supporting Fig. A1).
A secondary structure estimation was performed from the CD spectra
in the presence of DMPC/DPMG (3:1), and the secondary structure
elements of the different BP100 analogs are listed in Table 1. These
unusually short BP100 peptides are predominantly α-helical, with the
CF3-Bpg containing analogs showing even slightly more helix content
(around 75%) than thewild type peptide (61%). Thus, the CD conforma-
tional analysis together with the antimicrobial tests conﬁrms that CF3-
Bpg labeling of BP100 does not signiﬁcantly perturb neither the second-
ary structure nor the biological function of the peptide.
The orientation of α-helical peptides in a membrane can be roughly
assessed using oriented CD (OCD) in fully hydrated, macroscopically
alignedmembrane samples [79,103]. OCDexperimentswere performed
on BP100 in DMPC/DMPG (3:1) bilayers at different P/L ratios, from
moderate 1:100 up to a high peptide concentration of 1:12.5. In all
cases, the OCD spectra (Fig. 3) correspond to peptides with the long
axis of the α-helix parallel to the plane of the membrane, i.e. in
the surface-bound state or so-called “S-state”. This can be seen from
the pronounced negative band around 208 nm, which has stronger in-
tensity compared to the band around 223 nm. Moreover, from
the quite similar line shape of all spectra at wavelengths N200 nm it
can be inferred that there is no change in the ratio of the two bands
and thus no re-orientation of the peptide at higher P/L ratios. This be-
havior is in contrast to longer α-helical AMPs, many of which havebeen found to undergo a concentration-dependent re-alignment in
the membrane [40,47,50,79,104,105].
For α-helical peptides it is also possible to estimate the helix tilt
angle in a membrane using 15N NMR on a peptide labeled with 15N in
the backbone, using a macroscopically oriented sample with the bilayer
normal parallel to the magnetic ﬁeld. 15N NMR experiments were per-
formed on BP100 with a 15N-label at Leu8 in the same kind of oriented
DMPC/DMPG (3:1) bilayers as used for OCD, at P/L ratios of 1:50, 1:100
and 1:200. All three 15N NMR spectra in Fig. 4 show a narrow signal at
Fig. 3. Oriented CD of BP100 in DMPC/DMPG (3:1) bilayers at different peptide-to-lipid
molar ratios (P/L). The spectra are normalized to the same intensity (223 nm) to illustrate
the similarity in the line shapes.
P/L=1:100 BP100-7I-Bpg
A B
944 P. Wadhwani et al. / Biochimica et Biophysica Acta 1838 (2014) 940–94992 ppm, corresponding to peptides in a surface-bound orientation
(S-state) with τ close to 90° [27]. The P/L = 1:100 sample was also
measured with the bilayer normal perpendicular to the magnetic
ﬁeld, and the signal was shifted to 135 ppm, showing that the peptide
is rotating fast around the bilayer normal. This can also be seen from a
hydrated multilamellar vesicle sample, where all membrane orienta-
tions are present, and which is motionally averaged compared to the
dry peptide powder spectrum (see Fig. A2).
The chemical shift does not vary with the P/L ratio, indicating that
the helix orientation does not changewith the concentration of the pep-
tide in the membrane, in full agreement with the OCD results. It should
also be noted that to observe an NMR signal, a cross-polarization pulse
sequence was used to transfer polarization from 1H spins to 15N spins.
The best polarization transferwas foundwith an unusually shortmixing
time of 250 μs, whereas with a mixing time of 500 μs or 1000 μs no sig-
nal was observed. For longer AMPs, like the 21-mers PGLa andMSI-103,
we have often used mixing times of 500–1000 μs, with longer mixing
times being more suitable for the least mobile peptides (as determined
from 2H or 19F NMR) [39,40]. On the other hand, for the small cyclic
decapeptide gramicidin S, we also found that short mixing times
(100–200 μs) gave the best 15N NMR signal [45]. From our experience,300 200 100 0
ppm
50 25 0 -25 -50
ppm
50 25 0 -25 -50
ppm
P/L=1:200
P/L=1:100
P/L=1:50
A B C
Peptide powder
Fig. 4. Solid-state NMR spectra of BP100-8L-15N in oriented bilayers of DMPC/DMPG (3:1),
at three different P/L values. (A) 31P NMR spectra before the 15N NMR experiment. (B) 15N
NMR spectra. The top spectrum is froma dry peptide powder samplewithout lipid to illus-
trate the underlying chemical shift anisotropy. The chemical shift of the sharp peak in the
membrane sample is in all three cases 92 ppm, indicating a surface-bound orientation of
the helix. (C) 31P NMR spectra after the 15N NMR experiment, acquired to conﬁrm that
the sample has not dried out or deteriorated otherwise.the short mixing time of 250 μs is therefore indicative of a highly dy-
namical system, which implies that BP100 is very likely monomeric
and rather mobile per se.
OCD and 15N NMR using a single 15N-label can only give an approx-
imate tilt angle of the peptide, and the azimuthal rotation angle ρ is not
available from these experiments. They do not provide much detailed
information on whole-body ﬂuctuations either, nor on a potential
unraveling of the helix termini. Furthermore, neither OCD nor 15N
NMR is sensitive enough to address low peptide-to-lipid ratios under
usual experimental conditions, as the concentration range of both
methods is limited to about P/L ≥1:300. To obtain a more comprehen-
sive and detailed description of the peptide structural and dynamical
behavior, 19F NMR is thus considered to be the method of choice
[22–26,36,40–70]. To this aim, six individually 19F-labeled BP100 ana-
logs were synthesized and reconstituted in oriented bilayers of DMPC/
DMPG (3:1), just as for OCD and 15N NMR, but covering now a much
wider range of P/L ratios from 1:3000 up to 1:10, which is accessible
only by 19F NMR.
The lipid orientation of samples on glass plateswas checkedwith 31P
NMR, showing that lipid bilayerswerewell oriented, except at very high
peptide concentrations above P/L ≥1:20 where the lipid order gets
perturbed (see Fig. A3). From the 19F NMR spectra shown in Fig. 5, the
homonuclear 19F–19F dipolar coupling for each speciﬁc labeled position
is obtained from the splitting of the triplet [23]. The spectra in Fig. 5A of
the different Bpg-labeled peptides in lipid bilayers at P/L = 1:100 all
exhibitwell resolved dipolar splittings, which differ for the different po-
sitions (values are given in Table 2). The 19F dipolar splittings remain al-
most unchanged even at high concentration (Fig. 5B), indicating that
the peptide does not aggregate, in full agreement with the CD analysis.
From Fig. 5B and Table 2, it is thus clear that the orientation of BP100 in
the membrane does not change over the entire concentration range
from a P/L of 1:3000 to 1:10. These data also conﬁrm that the helical
structure of BP100 remains unchanged (including the peptide termini)
even at low concentration.
To determine whether the BP100 molecules are free to diffuse
rotationally within the plane of the membrane (on the millisecondppmppmppm
0  -1000  -1000  -1000  -100
ppm
P/L
1:3000
1:200
1:100
1:50
1:20
1:10
3L-Bpg
4F-Bpg
7I-Bpg
8L-Bpg
10Y-Bpg
11L-Bpg
0o 09tlit o tilt 0o 09tlit o tilt
Fig. 5. (A) 19F NMR spectra of oriented samples of BP100, labeledwith CF3-Bpg at different
positions, in DMPC/DMPG (3:1) bilayers at P/L = 1:100. (B) 19F NMR spectra of oriented
samples of BP100-7I-Bpg, in DMPC/DMPG (3:1) bilayers at different P/L ratios.
Table 2
19F–19F dipolar couplings (in kHz) of CF3-Bpg labeled BP100 analogs inDMPC/DMPG (3:1)
bilayers.
Different peptides at P/L = 1:100 BP100-7I-Bpg at different P/L
Peptide 0° 90° P/L ratio 0° 90°
BP100-3L-Bpg +5.1 −2.4 1:3000 +7.7 −3.8
BP100-4F-Bpg +1.0 −0.5 1:200 +7.7 −4.0
BP100-7I-Bpg +8.2 −4.1 1:100 +8.2 −4.1
BP100-8L-Bpg −5.2 +2.5 1:50 +8.0 −4.3
BP100-10Y-Bpg +3.2 −1.4 1:25 +8.6 −4.6
BP100-11L-Bpg +6.5 −3.2 1:10 +8.7 −5.3
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oriented sample, by placing it with the membrane normal parallel (0°)
as well as perpendicular (90°) to the external magnetic ﬁeld. The spec-
tra for both orientations are shown in Fig. 5, and the corresponding di-
polar couplings are given in Table 2. The splittings measured at 90°
are found to be scaled by a factor of approximately−1/2 compared to
the splittings measured at 0°. This indicates a fast rotational diffusion
of peptides around the bilayer normal [23], which again suggests that
BP100 is highly mobile in the membrane-bound state, and monomeric
like many other membrane-active peptides [23,44,47,48,50,74].
From the 19F-19F dipolar couplings of the different labeled positions,
the conformation and orientation of a peptide can be determined as de-
scribed in theMaterials andmethods section. For any speciﬁc values of τ
and ρ angles, the couplings are calculated for a given peptide conforma-
tion. Since we know from CD and OCD that BP100 and its analogs form
anα-helix in lipid bilayers, an ideal α-helical geometry was used in the
19F NMR data analysis. One point of interest, especially in view of the
very short BP100 sequence, is whether this structural assumption is
valid all the way up to the peptide termini. Fig. 6A shows the helical
wave plot of the dipolar couplings as a function of residue number.RMSD / kHz
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Fig. 6.Analysis of 19F NMRdata of BP100 inDMPC/DMPG (3:1) bilayers at P/L = 1:100 using the
sured at different labeled positions in the helix. (B) The same helical wave plotted around one
around the helix axis, according to a helical wheel view (see Fig. 1). Since all labels are on the
experimental and calculated splittings, for all τ and ρ values used in the calculation. For eac
pairs of angles. The RMSD is color-coded, and the lowest RMSD is marked in black. The red are
and calculated splittings, for all στ and σρ values used in the calculation. For each στ-σρ pair, the
The RMSD is color-coded, using the same scale as in (C), so that for example the black parts ofThe quality of the ﬁt is high, in the sense that the best-ﬁt curve ﬁts
well to all experimental data points. Since none of the data points devi-
ate from the ﬁtted curve, wemay conclude that BP100 forms a continu-
ous and compact α-helix all the way from Leu3 to Leu11.
To obtain reliable structural results, it is usually important to take
dynamics into account in the NMR data analysis of membrane-bound
peptides [71–73,75,76]. We may expect that this aspect is particularly
relevant for the short and compact BP100 helix, for which the 15N
NMR mixing time had already suggested an unusually high mobility.
The 19F NMR data were thus analyzed using an “explicit” dynamical
model, where the dynamics are described explicitly by whole-body
ﬂuctuations of the τ and ρ angles. It is assumed that these angles ﬂuctu-
ate on a timescale which is fast compared to the NMR experiment, so
that the 19F dipolar splittings reﬂect averages over these ﬂuctuations.
Furthermore, this model implies that ﬂuctuations can be described
with Gaussian probability distributions of angles, i.e. by an average
value τ0 (or ρ0) plus a width of the distribution στ (or σρ) [72]. The re-
sult of this advanced analysis is shown in Fig. 6 for BP100 in DMPC/
DMPG (3:1) at P/L = 1:100. There is a best ﬁt orientation correspond-
ing to τ = 156°, ρ = 159°, στ = 3° and σρ = 3°. In Fig. 6A and B the
helical curves corresponding to these parameter values are plotted to-
gether with the experimental data points. The ﬁt is reasonably good
with a best ﬁt RMSD = 0.83 kHz. Fig. 6C shows the RMSD as a function
of τ and ρ, using a color coding. To project the four-dimensional data
down to two dimensions, for each (τ,ρ) pair the lowest RMSD for any
particular combination of στ and σρ is plotted, meaning that for each
orientation (τ,ρ) the respective local (στ,σρ) optimum is used. These
considerations nowgive rise to an additional plot of the RMSD as a func-
tion of στ and σρ, shown in Fig. 6D. Here, analogously, for each (στ,σρ)
pair the values of τ and ρ giving the best ﬁt in each case are used.
The global best ﬁt gives small values of Gaussian widths στ and σρ,
indicating at ﬁrst sight that the peptide should be almost immobile.B
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explicit dynamicalmodel. (A) Best-ﬁt helical wave plotted against dipolar couplingsmea-
turn of the helix, with labeled positions marked at the angle corresponding to the position
same face of the helix, they cluster in one stretch of the helical wave. (C) RMSD between
h τ-ρ pair, the best-ﬁt values of στ and σρ are used, which can be different for different
a has an RMSD b0.3 kHz larger than the best-ﬁt value. (D) RMSD between experimental
best-ﬁt values of τ and ρ are used, which can thus be different for different pairs of angles.
both ﬁgures correspond to the same parameter values.
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Fig. 7.Helical waves for different tilt angles, generated for a hypothetical BP100-like pep-
tidewith ρ = 160°,στ = 10°, andσρ = 20°; the tilt angle is given in theﬁgure next to the
corresponding curve. For small tilt angles (10–30°), the region around 50° is most sensi-
tive to changes in τ, while for large tilt angles (40–80°), the region around 240° is most
sensitive.
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large range of τ values (from 110° to 160°) give almost the same
RMSD, as seen in Fig. 6C. The global best ﬁt has RMSD = 0.83 kHz,
while the entire region in red corresponds to orientations where
RMSD is still less than 1.1 kHz. All these helix tilt angles are therefore
compatible with the experimental 19F NMR data. Similarly, a wide
range of στ, and σρ values are also compatible with the RMSD, as seen
in Fig. 6D.We thus face an ambiguous situation in this 19F NMR analysis
of BP100,where the helix tilt angle has a very broad range of possible tilt
angles. For the azimuthal rotation angle ρ, the best ﬁt value ismuch bet-
ter deﬁned, as only the region from 155° to 165° gives an acceptable
RMSD.
To narrow down the ambiguity in the tilt angle, we refer back to
the 15N NMR and OCD data above (Figs. 3 and 4), which had shown
that BP100 is aligned essentially parallel to the membrane surface
in an S-state. To be sure that the CF3-Bpg-substitution had not affect-
ed the orientation of the 19F-labeled analogs compared to BP100-wt,
OCD was also performed on BP100-7I-Bpg, but there was no differ-
ence in the spectral lineshape (see Fig. A4A). As extra further control,
we also prepared doubly-labeled peptides, containing both 15N at
Leu8 as well as CF3-Bpg at position Leu3 or Ile7. However, no signif-
icant difference was seen between the singly-labeled and doubly-
labeled peptides in either the 31P, 15N or 19F NMR spectra, again
conﬁrming that the orientation of the peptide was not affected due
to 19F-labeling (see Fig. A4B and A4C), in line with the biological ac-
tivity tests above (see Table A1).
If we critically reconsider the 19F NMR data and accept an RMSD
value of 0.3 kHz above the best-ﬁt value of 0.8 kHz, then a tilt angle
of τ ≈ 110° is compatible with all the different experimental
methods used. This means that the amidated, uncharged C-terminus
of BP100 would point slightly deeper into the membrane than the
charged N-terminus (i.e. τ ≈ 110° between the membrane normal
and the helix axis running from N- to C-terminus). For this very plausi-
ble solution (also in the light of the 15N NMR and OCD results), we ob-
tain corresponding values of ρ ≈ 160°, στ ≈ 5°, and σρ ≈ 40° from
the dynamical 19F NMR analysis. We can thus reconcile all our orienta-
tional data into one comprehensive picture of BP100: The helical pep-
tide lies almost ﬂat on the membrane surface, with only a slightly
deeper immersion of the amidated C-terminus. The azimuthal rotation
angle is close to 160°, meaning that the charged Lys side chains point
out of the membrane into the aqueous layer, as expected. Furthermore,
the peptide is rather dynamic with a ﬂuctuating tilt of στ ≥ 5° and a
pronounced variation in σρ ≥ 40°.
4. Discussion
Solid-state NMR is a powerful method to determine the conforma-
tion, alignment and dynamics of peptides in oriented membrane
samples. Many important insights have been obtained this way on phe-
nomena like hydrophobic mismatch [19,20,75,106], on the role of an-
choring residues in hydrophobic peptides [37,106–108], and on the
mode of action of antimicrobial peptides, which have in some cases
been found to be inserted in the membrane in accordance with the for-
mation of transmembrane pores [46,109]. The general NMR approach,
based on the use of selective 2H- 15N- or 19F-labels, is routinely
established for longer α-helical peptides. However, the study of short
peptides, such as BP100with only 11 amino acids, is still an unmet chal-
lenge for several reasons that will be discussed below. These include (i)
the necessity of the peptide to assume a regular fold, (ii) the risk of
unraveling at the termini, (iii) the limited number of positions that are
suitable for selective labeling, (iv) the uneven distribution of labels
over the helical wheel, and (v) the possibility that a compact molecular
shape undergoes vigorous dynamics in ﬂuid membranes.
The traditional way to analyze helical peptides with selective 2H- or
19F-labels in the side chains is based on the GALA approach (geometric
analysis of labeled alanines) [19,20,38,47,50,58,74–76,105,106,108,109].In previous studies, peptides had a typical length of around 20 amino
acids, and the labels could be placed along the central stretch of the pep-
tide, far from the termini where unfolding or non-ideal helix geometries
may occur. Notably, it was shown for the transmembrane peptide
GWALP23 that the data from labels in positions 3 and 21 does not ﬁt to
a helical wave determined from the central positions 7–17 [37], indicat-
ing a partial unfolding of the helix beyond the ﬂanking Trp residues at ei-
ther end. Also in the case of the amphiphilic surface-bound peptide PGLa,
the label at position 20 (out of 21 amino acids) did not ﬁt well to the he-
lical wave based on the central stretch at P/L = 1:200 in DMPC, while at
P/L = 1:50 there was a good match [104]. These observations raise the
question whether and to what extent membrane-bound peptides may
have a tendency to unravel at their termini.
Our CD analysis of BP100 showed that this membrane-bound pep-
tide is highly α-helical, hence it fulﬁlls the ﬁrst of the above criteria
(i) to allow a more detailed solid-state NMR structure analysis.
Deconvolution of the CD data gave up to 87% helix content (Table 1),
suggesting that only 1–2 amino acids at the termini may not be folded
properly. It was indeed possible to ﬁt a helical wave to all of the data
points measured from six 19F-labels between positions 3 and 11
(Fig. 6A), which alleviates the second challenge (ii). OCD showed that
BP100 is oriented approximately ﬂat on the membrane surface
(Fig. 3), and the same helix alignmentwas estimated from the NMR sig-
nal of a single 15N-label in themiddle of the sequence (Fig. 4). To obtain
further details on the azimuthal rotation and the dynamical behavior of
BP100, a comprehensive 19F-NMR analysis was performed using six
CF3-Bpg labels. In previous studieswith a similar number of data points,
this approach had yielded highly accurate values for both τ and ρ. How-
ever, in the case of BP100, an additional problem was encountered due
to the fact that there are only very limited possibilities available for 19F-
labeling, as in challenge (iii). Out of the 11 amino acids in BP100, there
are only six hydrophobic positions that can be labeled with CF3-Bpg
(Leu3, Phe4, Ile7, Leu8, Tyr10, Leu11). The remaining ﬁve residues are
all charged, hence they are no good candidates for labeling with CF3-
Bpg because a reduction in the net charge of a peptide can reduce its an-
timicrobial activity and increase hemolytic side-effects [11,110].
All 19F-labels are located on the same face of the amphiphilic BP100
helix (Fig. 1), which turns out to be a major challenge (iv). A lack of la-
bels on one face of the helixmay under some circumstances dramatical-
ly reduce the informative value that can be extracted from the helical
wheel analysis, as is found to be the case here with BP100. The general
effect of having only half the sector labeled is analyzed in more detail in
the Supporting Information (Appendix B). As illustrated in Fig. 7, some
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critical information about the helix tilt angle than other regions. If a sec-
tor of only 180° is labeled, this may in some cases be sufﬁcient to get a
reliable ﬁt, but not in others, sowe cannot state a priori that the labeling
of an amphiphilic helix will not give an accurate orientation. The
degree of uncertainty in determining the helix tilt angle depends on
which part of the helical wave is accessible for labeling, and on the actu-
al alignment of the helix in the membrane. In the case of surface-bound
BP100, all 19F-labels happen to be located in the less informative region
of the helical wave, so the analysis suffers from considerable uncertainty
in the value of τ. It is obvious that for optimal results, the NMR labels
should be distributed as evenly as possible around the helix axis,
which will result in a unique solution with minimal uncertainty. This
is easily achieved in uniformly hydrophobic transmembrane sequences,
but more difﬁcult for amphiphilic peptides, especially when they are as
short as BP100. As demonstrated in Appendix B, it would be enough to
have just one additional data point from thepolar face of this helix to get
a reliable tilt angle for BP100. So far, there are no 19F NMR reporter
groups availablewith charged side chains, but several newhydrophobic
and polar 19F-labels have been recently custom-designed for 19F NMR
structure analysis based on a cyclobutane geometry [55,56]. There is
hope that the same framework may be suitable to generate charged
side chains carrying a CF3-reporter group, which would resolve chal-
lenges (iii) and (iv) by providing further data on the polar face of the
helix.
We conclude that in the present case of BP100 the 19F NMR analysis
must be accompanied by additional experiments such as 15N NMR and
OCD, to narrow down the ambiguity in the helix tilt angle. Nevertheless,
19F NMR has provided valuable information on the azimuthal angle,
ρ = 160°, indicating that the charged lysine side chains of BP100
point out of the membrane. Also, the range of compatible τ-values sug-
gests that the amidated C-terminus is slightly more inserted into the
membrane than the charged N-terminus. Furthermore, we ﬁnd that
the peptide is very mobile, with pronounced ﬂuctuations in the azi-
muthal angle (σρ ≥ 40°). This value is considerably higher than
σρ ≈ 20° found for the longer amphiphilic peptides PGLa and MSI-103
which were studied previously [72,74]. This ﬁnding indicates that
BP100 does not form oligomers in the membrane, but remains mono-
meric up to high peptide-to-lipid ratios. Such dynamical information
is not conclusively available from 15N NMR or OCD. In Table 3 we give
an overview of the different methods used here for BP100, and on the
information that can be gained from each method.
To address challenge (v), i.e. the short peptide may be vigorously
dynamic in the membrane, we used an advanced dynamical model in
the data analysis. In our previous, in-depth analyses of the amphipathic
α-helical peptides PGLa and MSI-103 there were no discrepancies be-
tween the 19F NMR and OCD results, nor with 2H NMR and 15N NMR
[40,47,50,79,105]. It was even possible to largely ignore the dynamics
of these long amphiphilic peptides, by using a simple Smol model to an-
alyze the NMR data [72,74]. This “implicit”model gave essentially the
same τ and ρ values as the more advanced dynamical model that had
to be applied here to the highly mobile BP100. In the implicit model, a
uniform averaging of the dipolar couplings is applied to all labeledTable 3
Overview of methods used to study membrane-bound BP 100 and information obtained.
Method Helicity Helix tilt
angle
Azimuthal
angle
Mobility P/L range Price
Solution CDa ✓ – – – 1:10–1:300 $
Oriented CDa ✓ ✓ – – 1:10–1:300 $
15N NMR (1 label) – ✓ – – 1:10–1:300 $$
19F NMR (6 labels) ✓ (✓)b ✓ ✓ 1:10–1:3000 $$$
a Circular dichroism is highly valuable to reveal β-sheet formation, which is often asso-
ciated with peptide aggregation, but which was not observed for BP100.
b Tilt angles can be determined with high accuracy provided the labels are favorably
distributed around the helix (see Appendix B).positions, using the same scaling factor Smol (which can take a value be-
tween 0 and 1). Interestingly, it was shown that this method grossly
underestimated the tilt angle of the highlymobile transmembrane pep-
tides of the WALP family [72,75,111], while it worked well for longer
and less mobile amphipathic helices like PGLa [72]. We also tried to an-
alyze the BP100 data using the implicit dynamic model (Fig. A5), which
showed a well-deﬁned RMSD minimum that describes a steeply tilted
and completely immobile peptide (τ = 154°, ρ = 159°, Smol = 1.00).
This picture is clearly incompatible with the OCD and 15N NMR results
and with all the information about peptide dynamics that we obtained
here from 19F NMR and from the mixing times used in 15N NMR. The
simpliﬁed analysis did not give any indication that there is a problem
due to the distribution of the labels on the helical wheel, so is clearly
not advisable to rely on the implicit dynamical analysiswithout comple-
mentary data from other methods, when the peptide is short and/or
highly mobile.
Short membrane-active peptides have been in the focus of research
not only in view of their cost-efﬁcient production, but also because they
pose intriguing questions concerning their mechanism of action. The
shortmultifunctional peptide BP100 is known to have a high antimicro-
bial and cell penetrating activity, but is not long enough to span the lipid
bilayer to form transmembrane pores. Our solid-state NMR and OCD
data showed that the surface-bound amphiphilic helix does not under-
go a concentration-dependent re-alignment in the membrane over
a wide range of peptide-lipid ratios from 1:3000 up to 1:10. This
makes an interesting contrast to the behavior of many other, longer
membrane-active peptides, which have been found to bind ﬂat to the
membrane surface only at low concentration. With increasing concen-
tration they tend to get ﬂipped into a tilted T-state, and they can even
assume a membrane-inserted I-state with an upright alignment that
implicates the formation of transmembrane pores. Our results on
BP100 are instead compatible with the view that these compact and
highly charged surface-bound helices can damage bacterial membranes
via the so-called “carpet”mechanism, wherebymembranes are perme-
abilized by peptideswithout the need for pore formation. A good indica-
tion for this mechanism is seen from the 31P NMR data (see Fig. A3),
which shows a considerable disturbance of the lipid bilayer at high pep-
tide concentration. However, further studies are needed to understand
how the very same peptide can act on the one hand as an antimicrobial
membrane-permeabilizing agent, and on the other hand as an efﬁcient
cell penetrating carrier without causing leakage in eukaryotic cells or
causing signiﬁcant toxic or hemolytic side effects.
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